Ilsung Is Co., Ltd. (KRX:003120)

South Korea flag South Korea · Delayed Price · Currency is KRW
22,400
-100 (-0.44%)
Dec 18, 2025, 10:25 AM KST
39.74%
Market Cap156.80B
Revenue (ttm)66.51B
Net Income (ttm)2.32B
Shares Out6.97M
EPS (ttm)340.76
PE Ratio66.03
Forward PEn/a
Dividend1,000.00 (4.46%)
Ex-Dividend DateDec 29, 2025
Volume6,534
Average Volume5,495
Open22,650
Previous Close22,500
Day's Range22,100 - 22,650
52-Week Range14,500 - 31,450
Beta-0.32
RSI39.43
Earnings DateFeb 26, 2026

About Ilsung Is

Ilsung Is Co., Ltd. operates as a pharmaceutical company in South Korea. Its products include antibiotics, analgesics, muscle relaxants, antipyretic-analgesics, antihistamine, neuropsychiatric, neuromuscular blocker/ central muscle relaxants, anti-coagulants, probiotics, vaccine, medical equipment, circulatory system drugs, contrast agents, muscle relaxants, diabetes treatments, osteopathic, digestive system medicines, anti-virals, anti-emetics, respiratory treatments, adrenal cortical steroids, anesthetics, antipyretics, and cardiovascular sys... [Read more]

Sector Healthcare
Founded 1954
Country South Korea
Stock Exchange Korea Stock Exchange
Ticker Symbol 003120
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.